HUP0203918A2 - Kvaterner ammóniumszármazékok és azok köhögés elleni szerekként történő alkalmazása - Google Patents

Kvaterner ammóniumszármazékok és azok köhögés elleni szerekként történő alkalmazása

Info

Publication number
HUP0203918A2
HUP0203918A2 HU0203918A HUP0203918A HUP0203918A2 HU P0203918 A2 HUP0203918 A2 HU P0203918A2 HU 0203918 A HU0203918 A HU 0203918A HU P0203918 A HUP0203918 A HU P0203918A HU P0203918 A2 HUP0203918 A2 HU P0203918A2
Authority
HU
Hungary
Prior art keywords
group
general formula
formula
precursor
stereoisomer
Prior art date
Application number
HU0203918A
Other languages
English (en)
Inventor
Gregory N. Beatch
Lewis Siu Leung Choi
Clive P. Page
Original Assignee
Ucb Farchim S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Farchim S.A. filed Critical Ucb Farchim S.A.
Publication of HUP0203918A2 publication Critical patent/HUP0203918A2/hu
Publication of HUP0203918A3 publication Critical patent/HUP0203918A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/14Quaternary ammonium compounds, e.g. edrophonium, choline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/14Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/18Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

Abstract

A találmány tárgyát képezik a (I) általános képletű vegyületek vagyazok gyógyászatilag elfogadható sója, észtere, amidja, komplexe,kelátja, szolvátja, sztereoizomerje, sztereoizomer-elegye, geometriaiizomerje, kristályos vagy amorf formája, metabolitja, bomlásiprekurzora vagy elővegyülete alkalmazása melegvérű állatokban köhögéskezelésére és/vagy megelőzésére szolgáló gyógyszerkészítményelőállítására - a képletben J jelentése egymástól függetlenül a (II),(III) vagy (IV) általános képletű csoport úgy, hogy amikor J jelentésea (II), (III) vagy (IV) általános képletű csoport, a találmányszerinti vegyületeket sorrendben a (V), (VI) vagy (VII) általánosképletű vegyületek jelentik, ahol a jelentése 0-4 értékű egész szám,R, R1, és E jelentése - többek között - CH2-R16-csoport, R16 jelentése- többek között - hidrogénatom vagy hidroxilcsoport, Y jelentése -többek között - hidrogénatom vagy -CH2R16-csoport, An-jelentése egygyógyászatilag elfogadható sav savaddíciós sója vagy egygyógyászatilag elfogadható sóból származó anion, azzal a feltétellel,hogy (a) amikor J jelentése a (II) általános képletű csoport, akkor Yjelentése a (VIII) általános képletű csoport; (b) amikor J jelentése a(III) általános képletű csoport, akkor Y jelentése a (VIII) általánosképletű csoport; (c) amikor J jelentése a (IV) általános képletűcsoport és Y jelentése nem a (VIII) általános képletű csoport, akkorR1 és E jelentése nem lehet egyaránt -CH2-R16 csoport; és (d) p, q ésr jelentése nem lehet egyszerre 0. A találmány tárgya továbbá a (I)általános képletű vegyület, annak gyógyászatilag elfogadható sója,észtere, amidja, komplexe, kelátja, szolvátja, sztereoizomerje,sztereoizomer-elegye, geometriai izomerje, kristályos vagy amorfformája, metabolitja, bomlási prekurzora vagy elővegyülete. Atalálmány tárgyát képzik továbbá az itt ismertetett vegyületekettartalmazó gyógyászati készítmények és ezek alkalmazásai. Ó
HU0203918A 1999-12-15 2000-12-15 Quaternary ammonium derivatives and their use as anti-tussive agent HUP0203918A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA2292343 1999-12-15
PCT/CA2000/001508 WO2001044167A1 (en) 1999-12-15 2000-12-15 Quaternary ammonium compounds and their use as anti-tussive agents

Publications (2)

Publication Number Publication Date
HUP0203918A2 true HUP0203918A2 (hu) 2003-03-28
HUP0203918A3 HUP0203918A3 (en) 2005-06-28

Family

ID=4164883

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203918A HUP0203918A3 (en) 1999-12-15 2000-12-15 Quaternary ammonium derivatives and their use as anti-tussive agent

Country Status (22)

Country Link
US (2) US20030181489A1 (hu)
EP (1) EP1254104B1 (hu)
JP (1) JP2003517034A (hu)
KR (1) KR20020092352A (hu)
CN (1) CN1423630A (hu)
AT (1) ATE293097T1 (hu)
AU (1) AU2334701A (hu)
BG (1) BG106815A (hu)
BR (1) BR0016427A (hu)
CZ (1) CZ20022097A3 (hu)
DE (1) DE60019465D1 (hu)
EE (1) EE200200315A (hu)
HU (1) HUP0203918A3 (hu)
IL (1) IL150181A0 (hu)
IS (1) IS6416A (hu)
MX (1) MXPA02006049A (hu)
NO (1) NO20022868L (hu)
NZ (1) NZ519747A (hu)
PL (1) PL355944A1 (hu)
RU (1) RU2002116212A (hu)
WO (1) WO2001044167A1 (hu)
ZA (1) ZA200205567B (hu)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2703324A (en) * 1950-08-30 1955-03-01 Bristol Lab Inc Basic ethers of aralkyl phenols and salts thereof
US2642434A (en) * 1951-09-05 1953-06-16 Sterling Drug Inc Quaternary ammonium salts of lower alkyl 4-substituted-2-(tertiaryaminoalkoxy) benzoates and their preparation
US2913459A (en) * 1954-12-09 1959-11-17 Eprova Ltd New quaternary ammonium compounds and process for the production thereof
GB919126A (en) * 1958-07-01 1963-02-20 Wellcome Found Quaternary ammonium compounds and their preparation
GB935613A (en) * 1960-02-04 1963-08-28 Wellcome Found Quaternary ammonium compounds and their preparation
US3840666A (en) * 1972-07-05 1974-10-08 Univ Michigan Anti-arrhythmic quaternary salt compositions and methods of use
US4048335A (en) * 1974-06-17 1977-09-13 The Regents Of The University Of Michigan Method of inhibiting myocardial ischemia in mammals using quaternary salts
DE2940765A1 (de) * 1979-10-08 1981-04-23 Basf Ag, 6700 Ludwigshafen Substituierte alkylammoniumsalze, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer
CN1145608C (zh) * 1998-06-09 2004-04-14 诺特兰药品有限公司 作为镇咳剂的季铵化合物

Also Published As

Publication number Publication date
ZA200205567B (en) 2003-10-13
DE60019465D1 (de) 2005-05-19
EP1254104B1 (en) 2005-04-13
HUP0203918A3 (en) 2005-06-28
WO2001044167A1 (en) 2001-06-21
RU2002116212A (ru) 2004-02-10
MXPA02006049A (es) 2004-08-23
IL150181A0 (en) 2002-12-01
ATE293097T1 (de) 2005-04-15
US20050197383A1 (en) 2005-09-08
JP2003517034A (ja) 2003-05-20
BG106815A (en) 2003-04-30
CZ20022097A3 (cs) 2002-11-13
NZ519747A (en) 2003-08-29
EE200200315A (et) 2003-08-15
AU2334701A (en) 2001-06-25
PL355944A1 (en) 2004-05-31
US20030181489A1 (en) 2003-09-25
IS6416A (is) 2002-06-12
NO20022868D0 (no) 2002-06-14
EP1254104A1 (en) 2002-11-06
KR20020092352A (ko) 2002-12-11
CN1423630A (zh) 2003-06-11
WO2001044167A8 (en) 2001-12-06
BR0016427A (pt) 2002-10-29
NO20022868L (no) 2002-08-14

Similar Documents

Publication Publication Date Title
AU8794291A (en) New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them
AU631068B2 (en) New peptide compounds, process for preparing these and pharmaceutical compositions containing them
ES8607297A1 (es) Un procedimiento para la preparacion de nuevos derivados de tiazolidina.
GEP19960467B (en) Method of producing derivatives of quinoline or their pharmaceutically acceptable esters or acid-additive salts
ES8107185A1 (es) Procedimiento para preparar piperidinas y pirrolidinas sus- tituidas
ES8404184A1 (es) Un procedimiento para la prepracion de nuevos derivados de acidos 2-carbamimidoil-1-,carbadestiapen-2-en-3-carboxilados.
HUP0204014A2 (hu) N-helyettesített ciklikus vagy aciklikus aminok kvaterner sói gyógyszerkészítményekkénti alkalmazása
US5221692A (en) Ether linked and relatively nonpungent analogues of N-nonanoyl vanillylamide
ES465225A1 (es) Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2).
ES454063A1 (es) Un procedimiento para la preparacion de nuevos derivados delalcohol bencilico.
HUP0203918A2 (hu) Kvaterner ammóniumszármazékok és azok köhögés elleni szerekként történő alkalmazása
PL304893A1 (en) Serotoninergic derivatives of ergoline
ATE48994T1 (de) Benzimidazol-derivat, verfahren zu seiner herstellung und pharmazeutische zusammensetzung.
DE69429753D1 (de) Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung
IE780901L (en) Tetrazolyl-piperidinyl amides
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
HUP0102447A2 (hu) Új oktahidro-6,10-dioxo-6H-piridazino[1,2-a][1,2]diazepin-1-karbonsav-származékok, eljárás a vegyületek előállítására és alkalmazásuk gyógyászati hatóanyagok előállítására
HUP0103077A2 (hu) Új benzotiadiazinvegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
GB1291644A (en) Substituted 1-indancarboxylic acids, their esters and salts
HUP0203034A2 (hu) Az (R)- és (S)-karnitin nitriloxi-származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
ATE395325T1 (de) Neues kristallines stilben-derivat und verfahren zu dessen herstellung
AU4327293A (en) 9-aminopyridazino(4',5' : 3,4)pyrrolo(2,1-a)isoquinolines and their use in the preparation of pharmaceutical compositions
RU94028194A (ru) 4-ацетил-5-n-иодфенил-1-карбоксиметил-3-гидрокси-2,5-дигидропиррол-2-он, проявляющий анальгетическую активность
IE41106L (en) Pharmaceutical compositions containing benzylamines
GB1185267A (en) Improvements in or relating to New Tetracycline Derivatives, a Process for their Preparation and a Therapeutic Composition obtained thereby